Abstract
Objective: To compare the effectiveness of "home sampling" with that of "office sampling" for testing partners to men and women infected with Chlamydia trachomatis.
Method: A randomised controlled effectiveness trial took place in the general community in Denmark. 1300 index women and 526 index men (⩾18 years) with a positive test result for C trachomatis were identified. Of these, 414 index women and 148 index men gave implied consent. Index patients were randomly assigned to provide their partner(s) through the past 12 months with either (1) a kit by which partner(s) could be tested by home sampling, or (2) a kit by which partner(s) could only be tested by seeing a healthcare professional (office sampling). The mainoutcome measure was the proportion of index patients who had at least one partner tested for C trachomatis.
Results: The proportion of index women with at least one partner tested was higher in the home sampling group (0.26) than in the office group (0.12) (difference 0.14; 95% CI 0.10 to 0.19; p<0.0001) and so it was for index men (0.15 v 0.03; difference 0.12; 95% CI 0.07 to 0.16; p<0.0001). Also the proportion of index women for whom at least one partner was identified as infected was higher in the home sampling group compared with the office group (0.11 v 0.07, p=0.01). The corresponding figures for index men were 0.06 v 0.01, p=0.02.
Conclusion: The effectiveness of partner testing is higher when partners of C trachomatis infected patients are offered home sampling than when they are offered office sampling.
Full Text
The Full Text of this article is available as a PDF (237.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersen Berit, Olesen Frede, Møller Jens K., Østergaard Lars. Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial. J Infect Dis. 2002 Jan 3;185(2):252–258. doi: 10.1086/338268. [DOI] [PubMed] [Google Scholar]
- Fenton K. A., Korovessis C., Johnson A. M., McCadden A., McManus S., Wellings K., Mercer C. H., Carder C., Copas A. J., Nanchahal K. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet. 2001 Dec 1;358(9296):1851–1854. doi: 10.1016/S0140-6736(01)06886-6. [DOI] [PubMed] [Google Scholar]
- Hillis S. D., Joesoef R., Marchbanks P. A., Wasserheit J. N., Cates W., Jr, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol. 1993 May;168(5):1503–1509. doi: 10.1016/s0002-9378(11)90790-x. [DOI] [PubMed] [Google Scholar]
- Klausner J. D., McFarland W., Bolan G., Hernandez M. T., Molitor F., Lemp G. F., Cahoon-Young B., Morrow S., Ruiz J., Young Women's Survey Team Knock-knock: a population-based survey of risk behavior, health care access, and Chlamydia trachomatis infection among low-income women in the San Francisco Bay area. J Infect Dis. 2001 Mar 8;183(7):1087–1092. doi: 10.1086/319276. [DOI] [PubMed] [Google Scholar]
- Martin D. H., Mroczkowski T. F., Dalu Z. A., McCarty J., Jones R. B., Hopkins S. J., Johnson R. B. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med. 1992 Sep 24;327(13):921–925. doi: 10.1056/NEJM199209243271304. [DOI] [PubMed] [Google Scholar]
- Schachter J. Chlamydial infections. West J Med. 1990 Nov;153(5):523–534. [PMC free article] [PubMed] [Google Scholar]
- Turner Charles F., Rogers Susan M., Miller Heather G., Miller William C., Gribble James N., Chromy James R., Leone Peter A., Cooley Phillip C., Quinn Thomas C., Zenilman Jonathan M. Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA. 2002 Feb 13;287(6):726–733. doi: 10.1001/jama.287.6.726. [DOI] [PubMed] [Google Scholar]